Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9490)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2015 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Biological Chemistry
ISSN
1949-8454
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nishiya N, Sakamoto Y, Oku Y, Nonaka T, Uehara Y. JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790M. World J Biol Chem 2015; 6(4): 409-418 [PMID: 26629323 DOI: 10.4331/wjbc.v6.i4.409] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v6/i4/409.htm |
| Number | Citing Articles |
| 1 |
Tsutomu Fukuda, Mizuho Anzai, Akane Nakahara, Kentaro Yamashita, Kazuaki Matsukura, Fumito Ishibashi, Yusuke Oku, Naoyuki Nishiya, Yoshimasa Uehara, Masatomo Iwao. Synthesis and evaluation of azalamellarin N and its A-ring-modified analogues as non-covalent inhibitors of the EGFR T790M/L858R mutant. Bioorganic & Medicinal Chemistry 2021; 34: 116039 doi: 10.1016/j.bmc.2021.116039
|
| 2 |
Alexander Gress, Vasily Ramensky, Joachim Büch, Andreas Keller, Olga V. Kalinina. StructMAn: annotation of single-nucleotide polymorphisms in the structural context. Nucleic Acids Research 2016; 44(W1): W463 doi: 10.1093/nar/gkw364
|
| 3 |
Alessia Belloni, Armanda Pugnaloni, Maria Rita Rippo, Silvia Di Valerio, Chiara Giordani, Antonio Domenico Procopio, Giuseppe Bronte. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review. Critical Reviews in Oncology/Hematology 2024; 194: 104246 doi: 10.1016/j.critrevonc.2023.104246
|
| 4 |
Gang Xiao, Xie Xu, Zhibo Chen, Jie Zeng, Jianjiang Xie. SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas. Clinical Medicine Insights: Oncology 2023; 17 doi: 10.1177/11795549231199915
|
| 5 |
Panagiotis Garantziotis, Stavros A. P. Doumas, Ioannis Boletis, Eleni Frangou. Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases. Journal of Clinical Medicine 2021; 10(11): 2262 doi: 10.3390/jcm10112262
|
| 6 |
Xinhao Peng, Hong Wu, Biqin Zhang, Chuan Xu, Jinyi Lang. A Novel Nucleic Acid Sensing-related Genes Signature for Predicting
Immunotherapy Efficacy and Prognosis of Lung Adenocarcinoma. Current Cancer Drug Targets 2024; 24(4): 425 doi: 10.2174/1568009623666230817101843
|
| 7 |
Tsutomu Fukuda, Teppei Umeki, Keiji Tokushima, Gao Xiang, Yuki Yoshida, Fumito Ishibashi, Yusuke Oku, Naoyuki Nishiya, Yoshimasa Uehara, Masatomo Iwao. Design, synthesis, and evaluation of A-ring-modified lamellarin N analogues as noncovalent inhibitors of the EGFR T790M/L858R mutant. Bioorganic & Medicinal Chemistry 2017; 25(24): 6563 doi: 10.1016/j.bmc.2017.10.030
|